top of page
Executive Spotlights

Zura Bio Announces Robert Lisicki as CEO and Director

Henderson, NV, April 8, 2024 (Zura Bio) -- Zura Bio, a company focused on advancing treatments for autoimmune and inflammatory conditions, has named Robert Lisicki as its new Chief Executive Officer and Board Director. Lisicki brings a wealth of experience from the pharmaceutical sector, where he has demonstrated leadership in research and development, commercial operations, and product development. He takes over from Dr. Someit Sidhu, the company's founding CEO, who will remain on the board. Lisicki's appointment signals a pivotal moment in Zura Bio's evolution as it aims to establish itself as a prominent player in the field of immunology.


Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma

Comments


Life Science Headlines
bottom of page